Stock listing
Atrium Therapeutics, Inc.
Selected listing: RNA · NASDAQ · USD · US
Atrium Therapeutics, Inc. (NASDAQ:RNA), Health Technology. Latest release Sep 2, 2026: Atrium Therapeutics to Participate in Upcoming Investor Conferences.
- Ticker
- NASDAQ:RNA
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
About Atrium Therapeutics, Inc.
Atrium Therapeutics, Inc. is a public company traded under the ticker RNA in the American market. Atrium Therapeutics focuses on developing innovative therapies to address unmet medical needs.
Latest news from Atrium Therapeutics, Inc.
Atrium Therapeutics to Participate in Upcoming Investor Conferences
September 2, 2026
Atrium Therapeutics Reports Second Quarter 2026 Financial Results
August 13, 2026
Atrium Therapeutics Announces FDA Clearance of Investigational New Drug Application for ATR 1072 for Treatment of PRKAG2 Syndrome
July 14, 2026
Atrium Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
June 23, 2026
Atrium Therapeutics Reports First Quarter 2026 Financial Results
May 14, 2026
Research Atrium Therapeutics, Inc.
Atrium Therapeutics, Inc. company profile
View the public company page for Atrium Therapeutics, Inc. on 6ix.
Atrium Therapeutics, Inc. news
Read company news and market updates connected to Atrium Therapeutics, Inc..
Atrium Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Atrium Therapeutics, Inc..